HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch

Labcorp launches rapid fentanyl test with 48-hour detection window

While fentanyl overdose deaths have been falling in recent years, use of the drug remains a major public health crisis in the U.S., and now Labcorp is launching a new test designed to detect the drug’s use for up to 48 hours after exposure.

By FierceBiotech · Apr 17, 2026 · via FierceBiotech
Labcorp launches rapid fentanyl test with 48-hour detection window

Image: FierceBiotech

Tags
pipelineformat:headlineheadlineFierceBiotech
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from Pipeline
All Pipeline →
Small pools, big ideas: How the rare disease community is reimagining clinical trials
PipelineFierceBiotech ↗
The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundre…
Apr 17, 2026
Qiagen launches latest diagnostic for bloodstream infections
PipelineFierceBiotech ↗
Qiagen has moved into syndromic testing for bloodstream infections with the launch of its newest offering.…
Apr 17, 2026
Merck unveils PD-1xVEGF bispecific data in NSCLC, remains tight-lipped on phase 3 plans
PipelineFierceBiotech ↗
More than a year after licensing its PD-1xVEGF bispecific, Merck & Co. has finally unveiled the first clin…
Apr 17, 2026